The Ethics of Patenting the BRCA Genes for Breast Cancer Research

The Ethics of Patenting the BRCA Genes for Breast Cancer Research J Value Inquiry (2017) 51:531–545 DOI 10.1007/s10790-017-9592-y The Ethics of Patenting the BRCA Genes for Breast Cancer Research John Jung Park Published online: 7 June 2017 Springer Science+Business Media Dordrecht 2017 1 BRCA Background Information Breast cancer is the second leading cause of death for women after heart disease. Both BRCA genes are strongly associated with hereditary breast cancer. Mutated BRCA genes are thought to be responsible for a majority of inherited breast cancer cases. Those with BRCA gene mutations have a high risk of developing breast cancer. This high risk of breast cancer for mutation carriers has led many of them to have prophylactic surgery that removes the breasts. In Europe and elsewhere, such as in Canada, Myriad has had patents on isolated forms of the BRCA genes since the mid-1990s. It is important to note that the patent is not on the BRCA genes in one’s body, but BRCA genes that have been isolated or extracted from the human body so that they may be studied in the laboratory. It is only through isolating genes from its natural environment that we may then examine the nucleotide sequences composing the genes and determine whether there are or are http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png The Journal of Value Inquiry Springer Journals

The Ethics of Patenting the BRCA Genes for Breast Cancer Research

Loading next page...
 
/lp/springer_journal/the-ethics-of-patenting-the-brca-genes-for-breast-cancer-research-rPj9WlvzPq
Publisher
Springer Netherlands
Copyright
Copyright © 2017 by Springer Science+Business Media Dordrecht
Subject
Philosophy; Ontology; Ethics; International Political Economy; Public International Law; Philosophy, general
ISSN
0022-5363
eISSN
1573-0492
D.O.I.
10.1007/s10790-017-9592-y
Publisher site
See Article on Publisher Site

Abstract

J Value Inquiry (2017) 51:531–545 DOI 10.1007/s10790-017-9592-y The Ethics of Patenting the BRCA Genes for Breast Cancer Research John Jung Park Published online: 7 June 2017 Springer Science+Business Media Dordrecht 2017 1 BRCA Background Information Breast cancer is the second leading cause of death for women after heart disease. Both BRCA genes are strongly associated with hereditary breast cancer. Mutated BRCA genes are thought to be responsible for a majority of inherited breast cancer cases. Those with BRCA gene mutations have a high risk of developing breast cancer. This high risk of breast cancer for mutation carriers has led many of them to have prophylactic surgery that removes the breasts. In Europe and elsewhere, such as in Canada, Myriad has had patents on isolated forms of the BRCA genes since the mid-1990s. It is important to note that the patent is not on the BRCA genes in one’s body, but BRCA genes that have been isolated or extracted from the human body so that they may be studied in the laboratory. It is only through isolating genes from its natural environment that we may then examine the nucleotide sequences composing the genes and determine whether there are or are

Journal

The Journal of Value InquirySpringer Journals

Published: Jun 7, 2017

There are no references for this article.

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off